Management of Aggression in Patients with Dementia
First-Line Approach: Non-Pharmacological Interventions
Non-pharmacological interventions should be implemented as first-line management for aggression in dementia before considering any medication. 1
Assessment and Identification of Triggers
Conduct thorough assessment to identify underlying causes:
- Pain or discomfort
- Medical conditions (infections, dehydration)
- Medication side effects
- Sensory deficits
- Fecal impaction
- Environmental triggers
Document triggers using ABC (antecedent-behavior-consequences) charting to identify patterns 1
Effective Non-Pharmacological Strategies
Environmental modifications:
- Create dementia-friendly spaces with adequate lighting
- Reduce noise and sensory overload
- Provide clear signage and color-coding
- Ensure comfortable seating and access to toilets 1
Behavioral approaches:
Caregiver interventions:
- Train caregivers in effective communication techniques
- Teach use of simple commands and calm tones
- Provide education and support resources
- Consider respite care options 1
Pharmacological Management
When non-pharmacological approaches are insufficient for severe aggression, medication may be considered, but with significant caution:
First-Line Pharmacological Options
Cholinesterase inhibitors may be considered first for behavioral symptoms 1
For severe behavioral symptoms with psychotic features:
- Atypical antipsychotics at lowest effective dose for shortest duration 1
- IMPORTANT CAUTION: Antipsychotics carry a black box warning for increased mortality in elderly patients with dementia-related psychosis (1.6-1.7 times higher risk of death) 3
- Risperidone and other antipsychotics are NOT FDA-approved for dementia-related psychosis 3
- Increased risk of cerebrovascular adverse events including stroke 3
Alternative Medications
When antipsychotics are contraindicated or ineffective:
- Trazodone: Starting at 25 mg/day (max 200-400 mg/day) 1
- Gabapentin for behavioral and psychological symptoms of dementia 1
- Brexpiprazole for agitation in Alzheimer's dementia 1
Medication Management Principles
- Use at lowest effective dose for shortest duration
- Attempt medication tapering after 6 months of symptom stabilization
- Consider combination therapy only after failed trials of two different medication classes
- Monitor regularly for side effects and effectiveness 1
- Discontinue ineffective medications 1
Pitfalls and Caveats
- Antipsychotic risks: Beyond mortality risk, watch for neuroleptic malignant syndrome and tardive dyskinesia 3
- Avoid benzodiazepines as first-line treatment due to risk of falls, confusion, and paradoxical agitation
- Limited evidence: Most medications show modest benefits with significant risks 4
- Short-term vs. long-term use: Antipsychotics may help aggression short-term (6-12 weeks) but have limited evidence for longer use and increasing risks 4
Monitoring and Reassessment
- Use quantitative measures like Neuropsychiatric Inventory Questionnaire (NPI-Q) to track symptoms
- Reassess at least every 6 months
- Evaluate for pain-related behaviors rather than relying on self-reporting
- Regularly review medication effectiveness and side effects 1
Remember that viewing aggressive behaviors as responses to internal or external stimuli helps guide appropriate treatment selection. The goal is to address underlying causes while minimizing risks associated with pharmacological interventions.